![conference banner](/images/conference-banner.jpeg)
Abstract
Introduction: Chronic inflammation of organs has been linked with various steps involved in carcinogenesis. Delta-opioid receptors (DOR) and farnesyl transferase (FT) inhibitors have the capability to obstruct various intracellular pathways affecting inflammation and cell proliferation. They become an effective targets for the treatment of inflammation and cancer.
Objectives: The work presented here reports the in-silico studies of anti-inflammatory and anti-cancerous properties of Callistemon viminalis derived natural compounds. Methods: This study includes quantitative structure activity relationship (QSAR) and quantitative structure toxicity relationship (QSTR). Biological activity and pharmacophore modeling of selected phyto-ligands against δ -opioid receptor (PDB ID: 4EJ4) and farnesyl transferase (PDB ID: 1S63) were evaluated. Results: Among 12 molecules investigated selectively 4 compounds exhibited excellent drug–likeness properties. Further, pharmacokinetic study revealed that these compounds were having minimal side effects. These compounds also showed a nicely bounded into the active site of DOR and FT with minimum binding energy through molecular docking. Pharmacophore model generated for these compounds showed potential anti-inflammatory and anti-cancer properties by showing appreciable interaction with DOR and FT. Conclusion: Hence, finally concluded compounds α-Terpineol, catechin, methyl gallate and ellagic acid have showed excellent binding energy and inhibitory constant for DOR and FT and it may be considered as a good inhibitor of the DOR and FT.Keywords: QSAR, QSTR, opioid receptors, farnesyl transferase, pharmacophore, pharmacokinetic.
Letters in Drug Design & Discovery
Title:Pharmacokinetic Evaluation of Callistemon viminalis Derived Natural Compounds as Targeted Inhibitors Against δ -Opioid Receptor and Farnesyl Transferase
Volume: 14 Issue: 4
Author(s): Kamal Ahmad, Abdul Roouf Bhat and Fareeda Athar
Affiliation:
Keywords: QSAR, QSTR, opioid receptors, farnesyl transferase, pharmacophore, pharmacokinetic.
Abstract: Introduction: Chronic inflammation of organs has been linked with various steps involved in carcinogenesis. Delta-opioid receptors (DOR) and farnesyl transferase (FT) inhibitors have the capability to obstruct various intracellular pathways affecting inflammation and cell proliferation. They become an effective targets for the treatment of inflammation and cancer.
Objectives: The work presented here reports the in-silico studies of anti-inflammatory and anti-cancerous properties of Callistemon viminalis derived natural compounds. Methods: This study includes quantitative structure activity relationship (QSAR) and quantitative structure toxicity relationship (QSTR). Biological activity and pharmacophore modeling of selected phyto-ligands against δ -opioid receptor (PDB ID: 4EJ4) and farnesyl transferase (PDB ID: 1S63) were evaluated. Results: Among 12 molecules investigated selectively 4 compounds exhibited excellent drug–likeness properties. Further, pharmacokinetic study revealed that these compounds were having minimal side effects. These compounds also showed a nicely bounded into the active site of DOR and FT with minimum binding energy through molecular docking. Pharmacophore model generated for these compounds showed potential anti-inflammatory and anti-cancer properties by showing appreciable interaction with DOR and FT. Conclusion: Hence, finally concluded compounds α-Terpineol, catechin, methyl gallate and ellagic acid have showed excellent binding energy and inhibitory constant for DOR and FT and it may be considered as a good inhibitor of the DOR and FT.Export Options
About this article
Cite this article as:
Ahmad Kamal, Bhat Roouf Abdul and Athar Fareeda, Pharmacokinetic Evaluation of Callistemon viminalis Derived Natural Compounds as Targeted Inhibitors Against δ -Opioid Receptor and Farnesyl Transferase, Letters in Drug Design & Discovery 2017; 14 (4) . https://dx.doi.org/10.2174/1570180814666161214114322
DOI https://dx.doi.org/10.2174/1570180814666161214114322 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Call for Papers in Thematic Issues
Navigating the Frontier: Probiotics' Promising Path in Combatting Viral Respiratory Infections, Spotlight on Coronaviridae.
Probiotics, well-known for their role in gut health, show promise in preventing and managing respiratory virus infections, particularly in children and at-risk populations. However, the profound influence of novel pathogenic viral RTIs such as coronaviruses has reshaped perspectives on the potential of probiotics. Despite their potential, significant gaps remain in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Magnetic Resonance Imaging of Uncommon Hepatic Mesenchymal Tumours: Haemangioendothelioma and Angiosarcoma
Current Medical Imaging QSPR and Flow Cytometry Analysis (QSPR-FCA): Review and New Findings on Parallel Study of Multiple Interactions of Chemical Compounds with Immune Cellular and Molecular Targets
Current Drug Metabolism Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors
Current Drug Targets Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report
Current Medical Imaging Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
Infectious Disorders - Drug Targets Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine
Current Pharmaceutical Design Gold Coordination Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
Current Enzyme Inhibition Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy
Current Medicinal Chemistry Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design Prolyl-Specific Peptidases and Their Inhibitors in Biological Processes
Current Chemical Biology Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and <i>in vitro</i> Studies
Current Cancer Drug Targets Implication of Heat Shock Protein 90 (HSP90) in Tumor Angiogenesis: A Molecular Target for Anti-Angiogenic Therapy?
Current Cancer Drug Targets Hierarchy of Knowledge Translation: From Health Problems to Ad-Hoc Drug Design
Current Medicinal Chemistry Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Therapeutic Strategies to Target TGF-β in the Treatment of Bone Metastases
Current Pharmaceutical Biotechnology Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System
Current Drug Targets Estrogen Receptor Beta (ERβ) Expression in Different Subtypes of Malignant Pleural Mesothelioma
Current Respiratory Medicine Reviews Intracellular Delivery of Potential Therapeutic Genes: Prospects in Cancer Gene Therapy
Current Gene Therapy